Literature DB >> 12624425

Tissue-specific targeting of the insulin receptor gene.

Rohit N Kulkarni1, Terumasa Okada.   

Abstract

The techniques to study the mechanisms that underlie the pathogenesis of disease processes have been revolutionized by the development of methods that allow spatiotemporal control of gene deletion or gene expression in transgenic and knockout animals. The ability to interfere with the function of a single protein in a specific tissue allows unprecedented flexibility for exploring gene function in both health and disease. The present review will summarize some of the different knockouts and transgenics generated recently to study type 2 diabetes and critically evaluate the techniques used to examine the function of the insulin receptor in two nonclassical insulin target tissues--the pancreatic islet and the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12624425     DOI: 10.1385/ENDO:19:3:257

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  115 in total

1.  Putting the genes for type II diabetes on the map.

Authors:  K Almind; A Doria; C R Kahn
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

Review 2.  Knockout mice challenge our concepts of glucose homeostasis and the pathogenesis of diabetes mellitus.

Authors:  C R Kahn; J C Brüning; M D Michael; R N Kulkarni
Journal:  J Pediatr Endocrinol Metab       Date:  2000       Impact factor: 1.634

Review 3.  Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance.

Authors:  A Virkamäki; K Ueki; C R Kahn
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

4.  Inhibition of hypothalamic neuropeptide Y gene expression by insulin.

Authors:  M W Schwartz; A J Sipols; J L Marks; G Sanacora; J D White; A Scheurink; S E Kahn; D G Baskin; S C Woods; D P Figlewicz
Journal:  Endocrinology       Date:  1992-06       Impact factor: 4.736

5.  Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene.

Authors:  W S Chen; P Z Xu; K Gottlob; M L Chen; K Sokol; T Shiyanova; I Roninson; W Weng; R Suzuki; K Tobe; T Kadowaki; N Hay
Journal:  Genes Dev       Date:  2001-09-01       Impact factor: 11.361

6.  Use of the tetracycline-controlled transcriptional silencer (tTS) to eliminate transgene leak in inducible overexpression transgenic mice.

Authors:  Z Zhu; B Ma; R J Homer; T Zheng; J A Elias
Journal:  J Biol Chem       Date:  2001-04-30       Impact factor: 5.157

Review 7.  Molecular insights into insulin action and secretion.

Authors:  C J Rhodes; M F White
Journal:  Eur J Clin Invest       Date:  2002-06       Impact factor: 4.686

8.  Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis.

Authors:  S Hoyer
Journal:  J Neural Transm (Vienna)       Date:  1998       Impact factor: 3.575

9.  Endocrine-metabolic relationships in patients with leprechaunism.

Authors:  M J Elders; H K Schedewie; J Olefsky; B Givens; F Char; D M Bier; D Baldwin; R H Fiser; S Seyedabadi; A Rubenstein
Journal:  J Natl Med Assoc       Date:  1982-12       Impact factor: 1.798

10.  Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality.

Authors:  R L Joshi; B Lamothe; N Cordonnier; K Mesbah; E Monthioux; J Jami; D Bucchini
Journal:  EMBO J       Date:  1996-04-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.